The Union Ministry of Health and Family Welfare has released a draft notification proposing a distinct blue vertical line on the labels of all antimicrobial medicines, a move aimed at improving identification and promoting the rational use of antibiotics in the country.

In a move aimed at accelerating drug development while maintaining regulatory oversight, India’s drug regulator has notified sweeping changes to the New Drugs and Clinical Trials (NDCT) Rules, 2019, introducing a faster “prior intimation” route for select test licences and sharply reducing approval timelines.

The amendments, notified on January 20, 2026, under G.S.R. 46(E), mark a significant shift in how manufacturers can produce new drugs and investigational products for clinical trials, bioavailability, bioequivalence studies, and analytical testing

Applications are invited online for filling up of position on a purely temporary basis, in the prescribed proforma. The details of the Sponsored Project under which engagement is proposed to be made is as under.

Post : Project Associate-I

Title of Project : Technical services: National Collection of Industrial Microorganisms
Name of Sponsoring Agency : NCL
Project Code : TSP024126